$BPMC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Blueprint Medicines Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Blueprint Medicines Corp. Get notifications about new insider transactions in Blueprint Medicines Corp for free.
Page: < prev 1 2 3 4 5 5 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 24 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Buy | M | 15.01 | 6,864 | 103,029 | 25,828 | 19 K to 25.8 K (+36.19 %) |
| Sep 24 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 16.28 | 3,143 | 51,168 | 2 | |
| Sep 24 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 85.49 | 3,143 | 268,695 | 42,838 | 46 K to 42.8 K (-6.84 %) |
| Sep 24 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 16.28 | 3,143 | 51,168 | 45,981 | 42.8 K to 46 K (+7.34 %) |
| Sep 21 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Option Exercise | M | 8.80 | 10,227 | 89,998 | 0 | |
| Sep 21 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Option Exercise | M | 8.80 | 3,030 | 26,664 | 0 | |
| Sep 21 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Option Exercise | M | 15.01 | 9,879 | 148,284 | 24,347 | |
| Sep 21 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 80.00 | 23,136 | 1,850,880 | 18,964 | 42.1 K to 19 K (-54.95 %) |
| Sep 21 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Buy | M | 8.80 | 10,227 | 89,998 | 42,100 | 31.9 K to 42.1 K (+32.09 %) |
| Sep 21 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Buy | M | 8.80 | 3,030 | 26,664 | 31,873 | 28.8 K to 31.9 K (+10.51 %) |
| Sep 21 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Buy | M | 15.01 | 9,879 | 148,284 | 28,843 | 19 K to 28.8 K (+52.09 %) |
| Sep 21 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 80.00 | 500 | 40,000 | 47,240 | 47.7 K to 47.2 K (-1.05 %) |
| Aug 21 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 20,000 | 176,000 | 47,170 | |
| Aug 21 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 74.60 | 8,597 | 641,336 | 141,434 | 150 K to 141.4 K (-5.73 %) |
| Aug 21 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 75.34 | 11,403 | 859,102 | 150,031 | 161.4 K to 150 K (-7.06 %) |
| Aug 21 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 20,000 | 176,000 | 161,434 | 141.4 K to 161.4 K (+14.14 %) |
| Aug 19 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 1.87 | 700 | 1,309 | 9,954 | |
| Aug 19 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 75.00 | 700 | 52,500 | 9,984 | 10.7 K to 10 K (-6.55 %) |
| Aug 19 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 1.87 | 700 | 1,309 | 10,684 | 10 K to 10.7 K (+7.01 %) |
| Aug 19 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 1.87 | 700 | 1,309 | 9,954 | |
| Aug 19 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 75.00 | 700 | 52,500 | 9,984 | 10.7 K to 10 K (-6.55 %) |
| Aug 19 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 1.87 | 700 | 1,309 | 10,684 | 10 K to 10.7 K (+7.01 %) |
| Jul 08 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 81.02 | 600 | 48,612 | 47,740 | 48.3 K to 47.7 K (-1.24 %) |
| Jul 08 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 80.44 | 25,407 | 2,043,739 | 48,340 | 73.7 K to 48.3 K (-34.45 %) |
| Jul 06 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 80.13 | 2,825 | 226,367 | 73,747 | 76.6 K to 73.7 K (-3.69 %) |
| Jul 06 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 80.21 | 1,300 | 104,273 | 76,572 | 77.9 K to 76.6 K (-1.67 %) |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 76.24 | 4,500 | 343,080 | 4,500 | |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Grant | A | 0.00 | 2,250 | 0 | 3,562 | 1.3 K to 3.6 K (+171.49 %) |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Borisy Alexis | Director | Option Exercise | A | 76.24 | 4,500 | 343,080 | 4,500 | |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Borisy Alexis | Director | Grant | A | 0.00 | 2,250 | 0 | 64,468 | 62.2 K to 64.5 K (+3.62 %) |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | COATS LONNEL | Director | Option Exercise | A | 76.24 | 4,500 | 343,080 | 4,500 | |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | COATS LONNEL | Director | Grant | A | 0.00 | 2,250 | 0 | 3,562 | 1.3 K to 3.6 K (+171.49 %) |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 76.24 | 4,500 | 343,080 | 4,500 | |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Grant | A | 0.00 | 2,250 | 0 | 3,562 | 1.3 K to 3.6 K (+171.49 %) |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Seely Lynn | Director | Option Exercise | A | 76.24 | 4,500 | 343,080 | 4,500 | |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Seely Lynn | Director | Grant | A | 0.00 | 2,250 | 0 | 3,562 | 1.3 K to 3.6 K (+171.49 %) |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Demetri George | Director | Option Exercise | A | 76.24 | 4,500 | 343,080 | 4,500 | |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Demetri George | Director | Grant | A | 0.00 | 2,250 | 0 | 6,024 | 3.8 K to 6 K (+59.62 %) |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Option Exercise | A | 76.24 | 4,500 | 343,080 | 4,500 | |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Grant | A | 0.00 | 2,250 | 0 | 77,872 | 75.6 K to 77.9 K (+2.98 %) |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Option Exercise | A | 76.24 | 4,500 | 343,080 | 4,500 | |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Grant | A | 0.00 | 2,250 | 0 | 127,904 | 125.7 K to 127.9 K (+1.79 %) |
| Jun 25 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 80.00 | 400 | 32,000 | 75,622 | 76 K to 75.6 K (-0.53 %) |
| Jun 24 2020 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Option Exercise | M | 36.05 | 2,300 | 82,915 | 30,200 | |
| Jun 24 2020 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Sell | S | 80.07 | 2,300 | 184,161 | 19,505 | 21.8 K to 19.5 K (-10.55 %) |
| Jun 24 2020 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Buy | M | 36.05 | 2,300 | 82,915 | 21,805 | 19.5 K to 21.8 K (+11.79 %) |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Borisy Alexis | Director | Option Exercise | M | 0.00 | 1,312 | 0 | 0 | |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Borisy Alexis | Director | Buy | M | 0.00 | 1,312 | 0 | 62,218 | 60.9 K to 62.2 K (+2.15 %) |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | COATS LONNEL | Director | Option Exercise | M | 0.00 | 1,312 | 0 | 0 | |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | COATS LONNEL | Director | Buy | M | 0.00 | 1,312 | 0 | 1,312 | 0 to 1.3 K |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Demetri George | Director | Option Exercise | M | 0.00 | 1,312 | 0 | 0 | |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Demetri George | Director | Buy | M | 0.00 | 1,312 | 0 | 3,774 | 2.5 K to 3.8 K (+53.29 %) |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Option Exercise | M | 0.00 | 1,312 | 0 | 0 | |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Buy | M | 0.00 | 1,312 | 0 | 125,654 | 124.3 K to 125.7 K (+1.06 %) |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 0.00 | 1,312 | 0 | 0 | |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 0.00 | 1,312 | 0 | 1,312 | 0 to 1.3 K |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Seely Lynn | Director | Option Exercise | M | 0.00 | 1,312 | 0 | 0 | |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Seely Lynn | Director | Buy | M | 0.00 | 1,312 | 0 | 1,312 | 0 to 1.3 K |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Option Exercise | M | 0.00 | 1,312 | 0 | 0 | |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 80.29 | 13,017 | 1,045,135 | 76,022 | 89 K to 76 K (-14.62 %) |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Buy | M | 0.00 | 1,312 | 0 | 89,039 | 87.7 K to 89 K (+1.50 %) |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 0.00 | 1,312 | 0 | 0 | |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 0.00 | 1,312 | 0 | 1,312 | 0 to 1.3 K |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Option Exercise | M | 37.11 | 4,600 | 170,706 | 61,800 | |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 79.00 | 4,600 | 363,400 | 15,250 | 19.9 K to 15.3 K (-23.17 %) |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Buy | M | 37.11 | 4,600 | 170,706 | 19,850 | 15.3 K to 19.9 K (+30.16 %) |
| Jun 22 2020 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Option Exercise | M | 18.00 | 2,500 | 45,000 | 8,966 | |
| Jun 22 2020 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Sell | S | 75.18 | 2,500 | 187,950 | 19,505 | 22 K to 19.5 K (-11.36 %) |
| Jun 22 2020 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Buy | M | 18.00 | 2,500 | 45,000 | 22,005 | 19.5 K to 22 K (+12.82 %) |
| Jun 11 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 1.87 | 700 | 1,309 | 10,654 | |
| Jun 11 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 75.00 | 700 | 52,500 | 9,984 | 10.7 K to 10 K (-6.55 %) |
| Jun 11 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 1.87 | 700 | 1,309 | 10,684 | 10 K to 10.7 K (+7.01 %) |
| Jun 04 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 66.03 | 235 | 15,517 | 9,984 | 10.2 K to 10 K (-2.30 %) |
| May 19 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Gift | G | 0.00 | 20,000 | 0 | 87,727 | 107.7 K to 87.7 K (-18.57 %) |
| May 14 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 20,000 | 176,000 | 67,170 | |
| May 14 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 63.93 | 9,568 | 611,682 | 141,434 | 151 K to 141.4 K (-6.34 %) |
| May 14 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 64.75 | 4,282 | 277,260 | 151,002 | 155.3 K to 151 K (-2.76 %) |
| May 14 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 65.77 | 6,150 | 404,486 | 155,284 | 161.4 K to 155.3 K (-3.81 %) |
| May 14 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 20,000 | 176,000 | 161,434 | 141.4 K to 161.4 K (+14.14 %) |
| Apr 07 2020 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Gift | G | 0.00 | 50,000 | 0 | 124,342 | 174.3 K to 124.3 K (-28.68 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 51.52 | 774 | 39,876 | 15,250 | 16 K to 15.3 K (-4.83 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 53.43 | 241 | 12,877 | 16,024 | 16.3 K to 16 K (-1.48 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 55.14 | 199 | 10,973 | 16,265 | 16.5 K to 16.3 K (-1.21 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 19,920 | 175,296 | 87,170 | |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 80 | 150 | 0 | |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 20,000 | 37,400 | 173,903 | |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 50.40 | 3,337 | 168,185 | 141,434 | 144.8 K to 141.4 K (-2.31 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 51.30 | 8,850 | 454,005 | 144,771 | 153.6 K to 144.8 K (-5.76 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 52.11 | 2,100 | 109,431 | 153,621 | 155.7 K to 153.6 K (-1.35 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 53.54 | 1,936 | 103,653 | 155,721 | 157.7 K to 155.7 K (-1.23 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 54.62 | 3,293 | 179,864 | 157,657 | 161 K to 157.7 K (-2.05 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 55.34 | 484 | 26,785 | 160,950 | 161.4 K to 161 K (-0.30 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 19,920 | 175,296 | 161,434 | 141.5 K to 161.4 K (+14.08 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 80 | 150 | 141,514 | 141.4 K to 141.5 K (+0.06 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 20,000 | 37,400 | 141,434 | 121.4 K to 141.4 K (+16.47 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 51.94 | 253 | 13,141 | 9,984 | 10.2 K to 10 K (-2.47 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 51.97 | 2,277 | 118,336 | 121,434 | 123.7 K to 121.4 K (-1.84 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 51.97 | 536 | 27,856 | 18,964 | 19.5 K to 19 K (-2.75 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 51.99 | 536 | 27,867 | 16,464 | 17 K to 16.5 K (-3.15 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | Landsittel Michael | Chief Financial Off ... | Sell | S | 51.97 | 400 | 20,788 | 17,350 | 17.8 K to 17.4 K (-2.25 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Sell | S | 51.98 | 617 | 32,072 | 21,683 | 22.3 K to 21.7 K (-2.77 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | Murray Christopher K. | SVP, Technical Oper ... | Sell | S | 51.94 | 402 | 20,880 | 13,848 | 14.3 K to 13.8 K (-2.82 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Sell | S | 51.96 | 135 | 7,015 | 20,365 | 20.5 K to 20.4 K (-0.66 %) |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 16.28 | 4,644 | 75,604 | 3,145 | |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | A | 54.13 | 28,500 | 1,542,705 | 28,500 | |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 16.28 | 4,644 | 75,604 | 43,509 | 38.9 K to 43.5 K (+11.95 %) |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Grant | A | 0.00 | 14,250 | 0 | 38,865 | 24.6 K to 38.9 K (+57.89 %) |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Option Exercise | A | 54.13 | 28,500 | 1,542,705 | 28,500 | |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Grant | A | 0.00 | 14,250 | 0 | 20,500 | 6.3 K to 20.5 K (+228.00 %) |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | A | 54.13 | 90,000 | 4,871,700 | 90,000 | |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Grant | A | 0.00 | 45,000 | 0 | 123,711 | 78.7 K to 123.7 K (+57.17 %) |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Option Exercise | A | 54.13 | 28,500 | 1,542,705 | 28,500 | |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Grant | A | 0.00 | 14,250 | 0 | 22,300 | 8.1 K to 22.3 K (+177.02 %) |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Landsittel Michael | Chief Financial Off ... | Option Exercise | A | 54.13 | 25,000 | 1,353,250 | 25,000 | |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Landsittel Michael | Chief Financial Off ... | Grant | A | 0.00 | 12,500 | 0 | 17,750 | 5.3 K to 17.8 K (+238.10 %) |
| Jan 14 2020 | BPMC | Blueprint Medicine ... | Demetri George | Director | Sell | S | 85.00 | 568 | 48,280 | 2,462 | 3 K to 2.5 K (-18.75 %) |
| Jan 14 2020 | BPMC | Blueprint Medicine ... | Demetri George | Director | Sell | S | 85.00 | 568 | 48,280 | 2,462 | 3 K to 2.5 K (-18.75 %) |
| Jan 14 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 16.28 | 7,763 | 126,382 | 7,789 | |
| Jan 14 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 16.28 | 7,763 | 126,382 | 7,789 | |
| Jan 14 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 85.16 | 7,763 | 661,097 | 15,865 | 23.6 K to 15.9 K (-32.86 %) |
| Jan 14 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 85.16 | 7,763 | 661,097 | 15,865 | 23.6 K to 15.9 K (-32.86 %) |
| Jan 14 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 16.28 | 7,763 | 126,382 | 23,628 | 15.9 K to 23.6 K (+48.93 %) |
| Jan 14 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 16.28 | 7,763 | 126,382 | 23,628 | 15.9 K to 23.6 K (+48.93 %) |
| Jan 09 2020 | BPMC | Blueprint Medicine ... | Demetri George | Director | Sell | S | 80.59 | 1,705 | 137,406 | 3,030 | 4.7 K to 3 K (-36.01 %) |
| Dec 23 2019 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Option Exercise | M | 37.11 | 4,600 | 170,706 | 66,400 | |
| Dec 23 2019 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 79.00 | 4,600 | 363,400 | 0 | 4.6 K to 0 (-100.00 %) |
| Dec 23 2019 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Buy | M | 37.11 | 4,600 | 170,706 | 4,600 | 0 to 4.6 K |
| Dec 19 2019 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Option Exercise | M | 8.80 | 10,000 | 88,000 | 3,030 | |
| Dec 19 2019 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 76.11 | 3,930 | 299,112 | 0 | 3.9 K to 0 (-100.00 %) |
| Dec 19 2019 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 76.87 | 6,070 | 466,601 | 3,930 | 10 K to 3.9 K (-60.70 %) |
| Dec 19 2019 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Buy | M | 8.80 | 10,000 | 88,000 | 10,000 | 0 to 10 K |
| Dec 18 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 1.87 | 415 | 776 | 11,354 | |
| Dec 18 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 75.00 | 415 | 31,125 | 0 | 415 to 0 (-100.00 %) |
| Dec 18 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 1.87 | 415 | 776 | 415 | 0 to 415 |
| Dec 06 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 77.25 | 192 | 14,832 | 0 | 192 to 0 (-100.00 %) |
| Nov 20 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 2,000 | 17,600 | 107,090 | |
| Nov 20 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 18,000 | 33,660 | 80 | |
| Nov 20 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 74.56 | 11,744 | 875,633 | 48,961 | 60.7 K to 49 K (-19.35 %) |
| Nov 20 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 75.36 | 7,656 | 576,956 | 60,705 | 68.4 K to 60.7 K (-11.20 %) |
| Nov 20 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 76.16 | 600 | 45,696 | 68,361 | 69 K to 68.4 K (-0.87 %) |
| Nov 20 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 2,000 | 17,600 | 68,961 | 67 K to 69 K (+2.99 %) |
| Nov 20 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 18,000 | 33,660 | 66,961 | 49 K to 67 K (+36.76 %) |
| Nov 19 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 1.87 | 415 | 776 | 11,769 | |
| Nov 19 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 75.00 | 415 | 31,125 | 0 | 415 to 0 (-100.00 %) |
| Nov 19 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 1.87 | 415 | 776 | 415 | 0 to 415 |
| Nov 05 2019 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,125 | 0 | 3,375 | |
| Nov 05 2019 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Buy | M | 0.00 | 1,125 | 0 | 1,125 | 0 to 1.1 K |
| Oct 30 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 20,000 | 37,400 | 193,903 | |
| Oct 30 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 20,000 | 37,400 | 48,961 | 29 K to 49 K (+69.06 %) |
| Oct 21 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 1.87 | 415 | 776 | 12,184 |